Global Insulin Pumps Market 2016-2020

  • ID: 3769435
  • Report
  • Region: Global
  • 57 pages
  • TechNavio
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 5

FEATURED COMPANIES

  • Animas
  • Bayer
  • GlySens
  • IA Collaborative
  • Insulet
  • Medtronic
  • MORE
About the Insulin Pumps Market

Diabetes is a common metabolic disease in which an individual's blood sugar level is high for a prolonged period. This is caused either because the pancreas stops secreting insulin or the body does not respond appropriately to insulin. The two types of diabetes include type 1 and type 2. In type 1 diabetes, the body does not produce sufficient insulin, and it is usually diagnosed in children and young adults. The most common type of diseases is type 2. In this type, the body is incapable of utilizing insulin.

Insulin pump therapy is the most preferred alternative delivery method of administrating insulin instead of insulin pens and needles. It is able to reduce the rate of recurrence of severe hypoglycemia and is capable of improving the quality of life for insulin pump users.

An insulin pump is a small-sized high-tech electronic device that can be connected to the body via an infusion set to deliver small doses of rapid-acting insulin to meet the basal needs. This device offers flexibility to people with type 1 diabetes.

The analysts forecast the global insulin pumps market to grow at a CAGR of 8.05% during the period 2016-2020.

Covered in this report

The report covers the present scenario and the growth prospects of the global insulin pumps market for 2016-2020. To calculate the market size, we consider revenue generated from the sale of insulin pumps.

The market is divided into the following segments based on geography:

- Americas
- APAC
- EMEA

The report, Insulin Pumps Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
- Animas
- Insulet
- Medtronic
- Roche Diagnostics

Other prominent vendors
- Bayer
- GlySens
- IA Collaborative
- MicroPort
- Senseonics
Tandem
- Valeritas

Market drivers
- Focus on diabetes management

Market challenges
- Inadequate reimbursements

Market trends
- Adoption of insulin pumps over conventional methods

Key questions answered in this report
- What will the market size be in 2020 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Animas
  • Bayer
  • GlySens
  • IA Collaborative
  • Insulet
  • Medtronic
  • MORE
PART 01: Executive summary
  • Highlights
PART 02: Scope of the report
  • Market overview
  • Top-vendor offerings
  • Research methodology
PART 03: Market research methodology
  • Economic indicators
PART 04: Introduction
  • Key market highlights
  • Background
PART 05: Insulin pumps: An overview
  • Complications of diabetes
  • Incidence and prevalence
  • Insulin pump therapy
PART 06: Cost analysis

PART 07: Market landscape
  • Market overview
  • Market size and forecast
PART 08: Five forces analysis

PART 09: Leading country: Insulin pumps market in the US
  • Market size and forecast
PART 10: Market segmentation by product type

PART 11: Geographical segmentation
  • Insulin pumps market in Americas
  • Insulin pumps market in EMEA
  • Insulin pumps market in APAC
PART 12: Market drivers
  • Increased prevalence of diabetes
  • Increase in older adult population
  • Focus on diabetes management
  • Rise in public awareness
PART 13: Impact of drivers
  • High cost
PART 14: Market challenges
  • Availability of alternatives
  • Inadequate reimbursements
  • Intense competition among vendors
PART 15: Impact of drivers and challenges

PART 16: Market trends
  • Advances in insulin pumps
  • Adoption of insulin pumps over conventional methods
  • Competitive scenario
PART 17: Vendor landscape
  • Market share analysis 2015
  • Animas
  • PART 18: Key vendor profiles
  • Insulet
  • Medtronic
  • Roche Diagnostics
  • Other prominent vendors
PART 19: Appendix
  • List of abbreviation
PART 20: About the Author

List of Exhibits

Exhibit 01: Product offerings
Exhibit 02: IDF estimate of diabetes population by region 2015
Exhibit 03: Cost breakdown of insulin pump therapy 2014
Exhibit 04: Cost breakdown of MDI 2014
Exhibit 05: Cost analysis of insulin pump consumables 2014
Exhibit 06: Cost analysis of MDI consumables for fast acting vial 2014
Exhibit 07: Cost analysis of MDI consumables for basal/long-acting insulin 2014
Exhibit 08: Cost comparison of MDI 2014
Exhibit 09: Average cost of cartridges offered by some of leading vendors 2014
Exhibit 10: Global insulin pumps market 2015-2020 ($ billions)
Exhibit 11: Five forces analysis
Exhibit 12: Insulin pumps market in the US 2015-2020 ($ millions)
Exhibit 13: Global insulin pumps market by geography 2015
Exhibit 14: Insulin pumps market in Americas 2015-2020 ($ millions)
Exhibit 15: Insulin pumps market in EMEA 2015-2020 ($ millions)
Exhibit 16: Insulin pumps market in APAC 2015-2020 ($ millions)
Exhibit 17: Global insulin pumps market by geography 2015-2020 ($ millions)
Exhibit 18: Global insulin pumps market by geography 2015-2020
Exhibit 19: Estimated percentage of older adult population 2012 and 2050
Exhibit 20: Impact of drivers
Exhibit 21: Impact of drivers and challenges
Exhibit 22: Vendor ranking of global insulin pumps market 2015
Exhibit 23: Global insulin pumps market share analysis 2015
Exhibit 24: Product matrix
Exhibit 25: Animas: Key takeaways
Exhibit 26: Insulet: Key takeaways
Exhibit 27:
Exhibit 28: Diabetes group by revenue 2013-2015 ($ billions)
Exhibit 29: Medtronic: Key takeaways
Exhibit 30: Diabetic care 2013-2015 ($ billions)
Exhibit 31: Roche Diagnostics: Key takeaways
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5

FEATURED COMPANIES

  • Animas
  • Bayer
  • GlySens
  • IA Collaborative
  • Insulet
  • Medtronic
  • MORE
New Report Released: - Global Insulin Pumps Market 2016-2020

The author of the report recognizes the following companies as the key players in the global insulin pumps market: Animas, Insulet, Medtronic, and Roche Diagnostics.

Other Prominent Vendors in the market are: Bayer, GlySens, IA Collaborative, MicroPort, Senseonics, Tandem, and Valeritas.

Commenting on the report, an analyst from the research team said: “A trend propelling market growth is the adoption of insulin pumps over conventional methods. Electronic insulin pumps are most commonly preferred over traditional treatment due to their effectiveness, safety, and better glucose results. Companies are developing new generation insulin pumps with advanced features that have allowed better compliance and integration of devices with IT. This has allowed people with diabetes to maintain their blood glucose levels and achieve a better lifestyle.”

According to the report, a key growth driver is the focus on diabetes management. Insulin pumps help people in diabetes management without physician support. With positive results of insulin pumps, there has been an increase in the awareness regarding insulin pumps among patients and physicians. Vendor-sponsored awareness programs facilitate cost free checking of blood glucose levels. This helps vendors to attract new customers. Further, companies like Roche Diagnostics are developing products that are designed to implement glucose monitoring technologies in disease management.

Further, the report states that one challenge that could hamper market growth is inadequate reimbursements by insurance carriers. Although reimbursements are being provided, they are inadequate owing to lack of adequate evidence on the accuracy of insulin pumps; some clinical studies have raised questions about the accuracy of these devices.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
5 of 5
- Animas
- Insulet
- Medtronic
- Roche Diagnostics
- Bayer
- GlySens
- IA Collaborative
- MicroPort
- Senseonics
- Tandem
- Valeritas.
Note: Product cover images may vary from those shown
6 of 5
Note: Product cover images may vary from those shown
Adroll
adroll